Cytosorbents

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Cytosorbents and other ETFs, options, and stocks.

About CTSO

CytoSorbents Corp. engages in critical care immunotherapy, investigation, and commercialization of blood purification technology. Its product portfolio includes CytoSorb, ContrastSorb XL, HemoDefend, VetResQ, and DrugSorb. 

CEO
Phillip P. Chan
CEOPhillip P. Chan
Employees
186
Employees186
Headquarters
Princeton, New Jersey
HeadquartersPrinceton, New Jersey
Founded
1997
Founded1997
Employees
186
Employees186

CTSO Key Statistics

Market cap
52.37M
Market cap52.37M
Price-Earnings ratio
-1.50
Price-Earnings ratio-1.50
Dividend yield
Dividend yield
Average volume
133.17K
Average volume133.17K
High today
$0.96
High today$0.96
Low today
$0.869
Low today$0.869
Open price
$0.91
Open price$0.91
Volume
116.39K
Volume116.39K
52 Week high
$4.29
52 Week high$4.29
52 Week low
$0.84
52 Week low$0.84
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.